Mitsubishi Tanabe’s Core Operating Profit Leaps 60.2% in 1st Half on Priority Products, Overseas Sales

Mitsubishi Tanabe Pharma’s group revenue in April-September hiked 6.4% year over year, along with buoyant core profit driven by the volume growth of priority products and overseas sales despite price cuts at home, according to its earnings report released on...read more